CPRIT oversight committee approves FY25 awards, product development supplements, prevention grants and $300 million bond authorization

The Cancer Prevention and Research Institute of Texas (CPRIT) Oversight Committee voted on a package of awards, contract delegations and financing on May 21 during its regular meeting in Austin.

Members approved the academic research program's slate of 47 awards requesting $69.7 million, approved six prevention awards, and approved a product-development supplemental slate funded from unused FY25 product-development dollars. The committee also delegated contract negotiation authority to the CEO and CPRIT staff for the approved awards and authorized the CEO to sign contracts on behalf of CPRIT. Members approved an agency request to authorize up to $300 million in bond financing for fiscal year 2026 through the Texas Public Finance Authority to fund prior-year awards and administrative expenses.

Why this matters: The votes move funding and contracting actions from recommendation to execution and free the agency to begin negotiating awards and contract terms for grantees and product-development companies. The bond authorization sets the finance capacity CPRIT intends to use next fiscal year to support previously approved grants and operations.

What the committee approved and related actions - Academic research: The committee approved the…